3rd Quarter - Report

PODESTA GROUP, INC. for AMPHASTAR PHARMACEUTICALS, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA Reform Abbreviated New Drug Application (ANDA) process and Follow-on-Biologics

LobbyistCovered position, as disclosed
RANDALL GERARD Senate Commerce, Science & Transportation
ARANTHAN JONES Health Policy Dir., Congressional Black Caucus
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.